Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis

Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis

Abstract Background Despite breakthroughs in treatment, metastatic castration-resistant prostate cancer (mCRPC) continues to pose a substantial problem. This meta-analysis sought to assess the efficacy and safety of immunotherapy-chemotherapy combinations in mCRPC. Methods A thorough search of Clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Azka Syed, Hasan Raza, Hameer Khan Khaskheli, Izza Rafique, Sameen Shahid, Nimra Shahzadi, Abdelrahman Sayed Al Komi, Abdullah A. Assiri, Muhammad Abbas Khokhar, Najeeb Ullah Khan
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Metastatic castration-resistant prostatic cancer
Immune checkpoint inhibitors
Immunotherapy
Docetaxel
MCRPC
Online Access:https://doi.org/10.1186/s12885-025-14575-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14575-1

Similar Items